We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Square Pharmaceuticals, the flagship company of Square Group, has reported a 12.89% growth in its net profit and a 6% increase in net revenue for the first half of the current fiscal year, which ended ...

Higher income from investments and increased profits from associated companies helped Square Pharmaceuticals post a 26 percent year-on-year rise in net profit in the October-December period of ...